CS83892A3 - Novel amides of carboxylic acids, process of their preparation andpharmaceutical compositions based thereon - Google Patents

Novel amides of carboxylic acids, process of their preparation andpharmaceutical compositions based thereon Download PDF

Info

Publication number
CS83892A3
CS83892A3 CS92838A CS83892A CS83892A3 CS 83892 A3 CS83892 A3 CS 83892A3 CS 92838 A CS92838 A CS 92838A CS 83892 A CS83892 A CS 83892A CS 83892 A3 CS83892 A3 CS 83892A3
Authority
CS
Czechoslovakia
Prior art keywords
tetrahydro
oxo
benzoic acid
trimethyl
ethyl
Prior art date
Application number
CS92838A
Other languages
Czech (cs)
English (en)
Inventor
Michael Klaus
Petr Mohr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CS83892A3 publication Critical patent/CS83892A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/121,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS92838A 1991-03-21 1992-03-19 Novel amides of carboxylic acids, process of their preparation andpharmaceutical compositions based thereon CS83892A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH86391 1991-03-21

Publications (1)

Publication Number Publication Date
CS83892A3 true CS83892A3 (en) 1992-10-14

Family

ID=4196940

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92838A CS83892A3 (en) 1991-03-21 1992-03-19 Novel amides of carboxylic acids, process of their preparation andpharmaceutical compositions based thereon

Country Status (21)

Country Link
US (1) US5216148A (es)
EP (1) EP0504695A1 (es)
JP (1) JPH07165709A (es)
KR (1) KR920018029A (es)
AU (1) AU649308B2 (es)
BR (1) BR9200951A (es)
CA (1) CA2061662A1 (es)
CS (1) CS83892A3 (es)
FI (1) FI921135A (es)
HU (1) HUT60465A (es)
IE (1) IE920907A1 (es)
IL (1) IL101242A (es)
IS (1) IS3823A (es)
MX (1) MX9201143A (es)
MY (1) MY131268A (es)
NO (1) NO921105L (es)
NZ (1) NZ241953A (es)
TW (1) TW221425B (es)
UY (1) UY23386A1 (es)
YU (1) YU24792A (es)
ZA (1) ZA921889B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
ZA9610853B (en) * 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
US7572788B2 (en) * 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US20040176358A1 (en) * 1999-04-30 2004-09-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
DE60007960T2 (de) * 1999-04-30 2004-10-21 Univ Michigan Ann Arbor Therapeutische Anwendungen von pro-apoptotischen Benzodiazepinen
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2001035964A1 (en) * 1999-11-18 2001-05-25 Antexpharma, Inc. Substituted 1-benzazepines and derivatives thereof
TW200508197A (en) * 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
US20050202055A1 (en) * 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
US20050272723A1 (en) * 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
US20060052369A1 (en) * 2004-09-07 2006-03-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
JP2008528448A (ja) * 2005-01-03 2008-07-31 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 新規化合物に関連する組成物および方法、ならびにその標的
EP1893218A4 (en) 2005-06-01 2011-01-12 Univ Michigan NON-SOLVATED BENZODIAZEPINE PREPARATIONS AND METHODS
US20070105844A1 (en) * 2005-10-26 2007-05-10 Regents Of The University Of Michigan Therapeutic compositions and methods
EP1948191B1 (en) 2005-11-01 2013-01-16 The Regents of the University of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) * 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
EP2037741B1 (en) 2006-06-09 2013-11-27 The Regents Of The University Of Michigan Benzodiazepine derivatives for use in the treatment of immune, inflammatory and proliferative disorders
CA2680017C (en) 2007-03-09 2013-11-12 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
CA2698248C (en) 2007-09-14 2017-08-29 The Regents Of The University Of Michigan Phenyl acyl guanidine derivatives as f1f0-atpase inhibitors and the use thereof
CA2703005A1 (en) 2007-11-06 2009-05-14 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
PT2254873E (pt) 2008-02-22 2014-08-29 Otsuka Pharma Co Ltd Compostos benzodiazepínicos e composições farmacêuticas que os contêm
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
JP5649577B2 (ja) 2009-08-21 2015-01-07 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン−2,4−ジオン化合物の製造方法
EP2470020A4 (en) 2009-09-18 2013-03-13 Univ Michigan BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
CA2780333C (en) 2009-11-17 2016-05-24 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
AU2010322287B2 (en) 2009-11-17 2014-04-03 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
AU2011245441B2 (en) 2010-04-29 2014-12-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE3818830A1 (de) * 1988-06-03 1989-12-14 Boehringer Mannheim Gmbh Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel
AU626881B2 (en) * 1988-07-14 1992-08-13 F. Hoffmann-La Roche Ag Benzofused heterocyclics used as pharmaceuticals

Also Published As

Publication number Publication date
EP0504695A1 (de) 1992-09-23
AU649308B2 (en) 1994-05-19
IL101242A0 (en) 1992-11-15
IL101242A (en) 1995-12-08
IE920907A1 (en) 1992-09-23
HU9200871D0 (en) 1992-05-28
UY23386A1 (es) 1992-11-05
FI921135A (fi) 1992-09-22
FI921135A0 (fi) 1992-03-17
HUT60465A (en) 1992-09-28
KR920018029A (ko) 1992-10-21
AU1108992A (en) 1992-09-24
JPH07165709A (ja) 1995-06-27
NZ241953A (en) 1994-11-25
TW221425B (es) 1994-03-01
IS3823A (is) 1992-09-22
NO921105L (no) 1992-09-22
ZA921889B (en) 1992-11-25
MY131268A (en) 2007-07-31
US5216148A (en) 1993-06-01
NO921105D0 (no) 1992-03-20
BR9200951A (pt) 1992-11-17
MX9201143A (es) 1992-10-01
CA2061662A1 (en) 1992-09-22
YU24792A (sh) 1994-09-09

Similar Documents

Publication Publication Date Title
CS83892A3 (en) Novel amides of carboxylic acids, process of their preparation andpharmaceutical compositions based thereon
KR960000852B1 (ko) 퀴놀린형 메발로노락톤
JP6715357B2 (ja) イミダゾピリジンアミンフェニル誘導体およびその使用
KR19990071542A (ko) 레티노이드형 생리활성을 갖는 테트라히드로나프타렌, 크로만,티오크로만 및 1,2,3,4-테트라히드퀴놀린 카르복실산의 아릴 또는 헤테로아릴 아미드
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
PL186404B1 (pl) Arylowe i heteroarylowe amidy kwasów karboksylowych posiadające czynność retynopodobną
AU2001249619A1 (en) Carbamate caspase inhibitors and uses thereof
EP1268425A2 (en) Carbamate caspase inhibitors and uses thereof
JPH01125322A (ja) アルドース還元酵素阻害剤
US3349088A (en) Therapeutically valuable 1, 2-dihyro-1, 2, 4-benzotriazine derivatives and process for preparation thereof
SU999972A3 (ru) Способ получени производных пиридо-(1,2-а) пиримидина или их фармацевтически приемлемых солей,или их оптически активных изомеров
WO1998022442A2 (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds and their use as cyclooxygenase i (cox 1) inhibitors
HUT65778A (en) Process for preparing hydroxyamidine derivatives and pharmaceutical comp. containing them
HU200761B (en) Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
PL166481B1 (en) Method of obtaining novel bezazepine compounds
US4801590A (en) Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals
US4109087A (en) 1,4- AND 4,10-Dihydro-4-oxo-pyrimido[1,2-a]benzimidazole-3-carboxylic acid amides
EP0356673A2 (en) Substituted 5,6,7,8-tetrahydroimidazo[1,5-a]pyridines and process for their preparation
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
JP2686887B2 (ja) ピペリジノ−3,4−ジヒドロカルボスチリル誘導体
US4016267A (en) Sulfacytosine derivatives
EP0089426B1 (en) 2-amino-6-biphenylacetic acids
JPH02196769A (ja) 新規なスルホンアニリド誘導体
SI9210247A (sl) Novi amidi karboksilne kisline
US4146626A (en) 8-adamantylaminomethyl ergolene derivatives